Methods And Compositions For The Targeted Modification Of A Genome

Patent No. EP3460063 (titled "Methods And Compositions For The Targeted Modification Of A Genome") was filed by Regeneron Pharmaceuticals on Oct 15, 2014. The application was issued on Mar 13, 2024.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
WUESTHOFF & WUESTHOFFDec 12, 2024WICHMANN

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3460063

REGENERON PHARMACEUTICALS
Application Number
EP18188401A
Filing Date
Oct 15, 2014
Status
Granted And Under Opposition
Feb 9, 2024
Publication Date
Mar 13, 2024